UK markets closed

Prelude Therapeutics Incorporated (PRLD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.8600-0.1300 (-3.26%)
At close: 04:00PM EDT
3.8600 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
92,198
103,393
92,889
86,778
48,177
Selling general and administrative
30,967
28,884
30,651
26,957
10,586
Total operating expenses
123,165
132,277
123,540
113,735
58,763
Operating income or loss
-123,165
-132,277
-123,540
-113,735
-58,763
Total other income/expenses net
3,526
10,445
8,102
2,041
1,834
Income before tax
-119,639
-121,832
-115,438
-111,694
-56,929
Income from continuing operations
-119,639
-121,832
-115,438
-111,694
-56,929
Net income
-119,639
-121,832
-115,438
-111,694
-56,929
Net income available to common shareholders
-119,639
-121,832
-115,438
-111,694
-56,929
Basic EPS
-2.15
-
-2.44
-2.43
-4.56
Diluted EPS
-2.15
-
-2.44
-2.43
-4.56
Basic average shares
54,881
-
47,372
46,050
12,478
Diluted average shares
54,881
-
47,372
46,050
12,478